SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is actively trending following its recent financial report, which saw a beat on Q4 expectations but provided a weaker outlook for the next quarter, primarily attributed to persistent supply constraints. This has sparked a divided conversation among investors; many highlight concerns over the company's valuation and turnaround execution, while others emphasize robust demand and strategic government support for domestic chip manufacturing as strong long-term tailwinds.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is commanding attention as its Breakthrough Therapy Designation for pemvidutide in MASH and obesity ignites intense community speculation around a potential buyout or strategic partnership. With significant short interest, many investors are actively discussing the possibility of a major rerating or acquisition by a pharmaceutical giant, viewing the stock as currently undervalued within the thriving GLP-1 sector.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing significant trending activity following reports of robust early prescription data for its new oral weight-loss medication, which the community views as a substantial market advantage. Investors are highly optimistic about the company's position as a leader in the expanding oral GLP-1 sector, anticipating a re-evaluation of its valuation amid strong demand.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind (MNKD) is generating buzz due to an impending FDA decision on an Afrezza label update, with a target action date of January 23, 2026, which the community hopes will clarify dose conversion and boost adoption. Supporters are optimistic about this and other 2026 catalysts, including potential pediatric approval and international market growth, pointing to recent record quarterly revenues. Conversely, skeptics highlight historical challenges, management's track record, and recent insider selling, actively debating the company's long-term value against its pipeline potential and partnerships.

RYVYL Inc. is a financial technology company that develops software platforms and tools that are focused on providing global payment acceptance and disbursement capabilities. It offers an innovative payment platform-as-a-service that redefines global payment solutions, enabling seamless business-to-business, consumer-to-business, and peer-to-peer transactions worldwide. The company leverages advanced electronic payment technology to deliver seamless financial solutions across global markets. It operates through two geographical segments: North America and International. The company was founded on April 10, 2007 and is headquartered in San Diego, CA.

Ryvyl Inc

Ryvyl Inc. is trending as its highly anticipated merger with Roundtable Digital progresses, marked by recent strategic partnership announcements and S-4 filings. Community discussion focuses on the company's perceived undervaluation, the potential for a low-float dynamic, and the upcoming reverse stock split as a necessary step for NASDAQ compliance, which is crucial for the combined Web3 media platform and Bitcoin treasury. Despite ongoing volatility, many believe the strengthened management team and the transformative merger present significant long-term upside.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as the community eagerly discusses the finalized deal for a US joint venture involving TikTok, where Oracle plays a pivotal role in cloud infrastructure and security. Many anticipate this could drive significant new revenue and solidify Oracle's standing in the AI and sovereign cloud sectors, though some maintain caution regarding the broader impact on its valuation and existing debt.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano is currently experiencing a significant surge following news of its all-stock merger with AI cloud computing firm Corvex, which also announced a long-term NVIDIA H200 GPU deployment. This has ignited strong community discussion, with many anticipating a short squeeze and parabolic price movement due to the stock's notably low float. However, some traders are urging caution, highlighting that the NVIDIA news relates to GPU usage rather than a direct partnership and pointing to potential dilution.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community keenly debates recent announcements from Elon Musk regarding the deployment of robotaxis in Austin without in-car safety monitors, coupled with potential FSD approval in Europe and timelines for humanoid robot sales. Enthusiasts see these developments as a significant leap towards Tesla's vision as an AI and mobility platform, driving strong bullish sentiment. Conversely, many skeptics remain critical, labeling the news as a "pump and dump" tactic ahead of upcoming earnings, citing concerns over product execution and previous unfulfilled promises.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending as its agentic AI capabilities gain recognition, highlighted by its Screen Agent achieving a #1 benchmark ranking for enterprise automation. Despite recent volatility fueled by community debate over insider stock sales, many investors view current price action as a prime buying opportunity, confident in the company's strong fundamentals and leadership in the growing AI sector.

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

Transmedics is experiencing significant buzz following strong Q3 results, robust revenue growth, and key FDA approval for its next-generation OCS Heart trial, all contributing to a very bullish sentiment among investors. The community is actively discussing record flight volumes, imminent European market expansion, and the potential for a substantial re-rating, viewing the company as holding a near-monopoly in the critical organ transplant technology sector despite continued short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies

Berkshire Hathaway headlines new Zacks research reports, with strong insurance performance, cash strength and diversified growth drivers.

Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel

Berkshire Hathaway's shares have edged past its industry, backed by insurance growth, rising float, strong cash and expanding investments, including Japan.

Joseph Stilwell Sells 19,229 Shares of Kingsway Financial Services (NYSE:KFS) Stock

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 19,229 shares of the business's stock in a transaction dated Monday, December 22nd. The stock...

Kingsway Financial Services (NYSE:KFS) Director Sells 19,229 Shares

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 19,229 shares of the company's stock in a transaction on Monday, December 22nd. The shares were...

Kingsway Financial Services (NYSE:KFS) CEO Sells $399,600.00 in Stock

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) CEO John Taylor Maloney Fitzgerald sold 30,000 shares of the business's stock in a transaction dated Tuesday, December 23rd...

Kingsway Financial Services (NYSE:KFS) Director Joseph Stilwell Sells 10,429 Shares

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 10,429 shares of the company's stock in a transaction dated Tuesday, December 16th. The shares...

Insider Selling: Kingsway Financial Services (NYSE:KFS) Director Sells 34,269 Shares of Stock

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 34,269 shares of Kingsway Financial Services stock in a transaction on Monday, December 15th...

Insider Selling: Kingsway Financial Services (NYSE:KFS) Director Sells 35,000 Shares of Stock

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 35,000 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an...

Kingsway Financial Services (NYSE:KFS) Director Joseph Stilwell Sells 20,000 Shares

Kingsway Financial Services, Inc. (NYSE:KFS - Get Free Report) (TSE:KFS) Director Joseph Stilwell sold 20,000 shares of the stock in a transaction on Tuesday, December 9th. The shares were sold at an...

Greenhaven Road Investment Management L.P. Purchases 554,891 Shares of Kingsway Financial Services, Inc. $KFS

Greenhaven Road Investment Management L.P. increased its position in shares of Kingsway Financial Services, Inc. (NYSE:KFS - Free Report) (TSE:KFS) by 73.4% during the second quarter, according to...

Kingsway Financial Services, Inc. operates as a holding company. The firm engages in the provision of financial services. It operates through the following segments: Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment includes excellent businesses in the Automotive and HVAC markets. It continues to expand its portfolio of high-quality operating companies through organic growth and disciplined M&A. The Kingsway Search Xcelerator segment is involved in review of billing rates and product prices are performed regularly and rates can be adjusted to reflect prevailing marketing expectations. The company was founded on September 19, 1989 and is headquartered in Chicago, IL.

Kingsway Financial Services Inc.

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

Current Price	$13.39
Prev Close	$13.50
Open	$13.54
Dividend Yield	0.00%
50-Day Moving Average	$12.91
Beta	0.53
Avg. Volume	74,375.00
PE Ratio	-31.60

52-Week High	$16.80
52-Week Low	$7.06
Market Capitalization	$383.15M
EPS (Annual)	-$0.3248
Price to Book	23.01
Revenue Per Employee	$259,852.19
Enterprise Value/EBITDA	N/A

KFS
Kingsway Financial Services Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KFS News

KFSKingsway Financial Services Inc.